Log In
BCIQ
Print this Print this
 

V0498

  Manage Alerts
Collapse Summary General Information
Company Pierre Fabre Group
DescriptionLow dosage of oromucosal Ibuprofen
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat acute sore throat pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today